Application status of using clopidogrel during perioperative period of percutaneous coronary intervention
- VernacularTitle:氯吡格雷在经皮冠状动脉介入术围手术期中的应用现状
- Author:
Hui WU
;
Jun YANG
;
Jia-Wang DING
;
Wen-Hui LI
;
Song LI
;
Li LI
;
- Publication Type:Journal Article
- Keywords:
clopidogrel;
pereutaneous coronary intervention;
restenosis;
stent thrombosis
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2004;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
Percutaneous coronary intervention(PCI) has become one of the most important therapeutic methods for atherosclerotic heart disease(AHD),but the following complications such as stent thrombosis and restenosis af- fected its long-term efficacy.Platelet activation was a key component of thrombosis of during perioperative period PCI.As one of the most effective antiplatelet drugs,clo- pidogrel has been established its important role in preven- ting thrombosis during perioperative period of PCI.After several large-scale clinical trials in recent years.
